サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：安定同位体標識化合物市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2029年
市場調査レポート
商品コード
1359056

安定同位体標識化合物市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2029年

Stable Isotope Labeled Compounds Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Application ; By End User ; By Region

出版日
ページ情報
英文 400 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
安定同位体標識化合物市場- 世界の規模、シェア、動向分析、機会、予測レポート、2019-2029年
出版日: 2023年09月18日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

安定同位体標識化合物の世界市場規模は2029年までに3億9,700万米ドルに達する

世界の安定同位体標識化合物市場は、製薬・バイオテクノロジー分野での研究開発活動の活発化と、増加する疾病の治療への関心の高まりにより、活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consulting社は、最近の調査で、2022年の世界の安定同位体標識化合物市場規模を3億350万米ドルと推定しました。2023年から2029年の予測期間中、BlueWeave社は世界の安定同位体標識化合物市場規模がCAGR 3.9%で成長し、2029年には3億9,671万米ドルに達すると予測しています。世界の安定同位体標識化合物市場の主な成長促進要因には、研究活動の急増や製薬・バイオテクノロジー分野での分析研究の動向の高まりなどがあります。がんの罹患率の増加は、安定同位体標識化合物を用いた分析調査を顕著に後押ししています。この市場は、特に個別化医療と医薬品における分析活動の需要増を主因として、成長するものと思われます。この収束は、市場の力強い成長の機会となります。2022年、米国では、特に生殖器系と消化器系に影響を及ぼす、約191万件の新たながん症例が発生し、市場の可能性がさらに強調されました。プロテオミクス研究と同様に、栄養補助食品のがん代謝への影響を理解する上で安定同位体トレーシングが果たす役割は、市場拡大に貢献しました。これらの進歩は、市場の堅調な成長への期待を支えるものでした。しかし、安定同位体標識化合物の高コストと熟練した専門家の不足が、予測期間中の市場全体の成長を抑制すると予想されています。

当レポートの詳細な分析により、世界の安定同位体標識化合物市場の成長可能性、今後の動向、統計に関する情報を提供します。また、総市場規模の予測を促進する要因も取り上げています。当レポートは、世界の安定同位体標識化合物市場の最新技術動向と、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することをお約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の安定同位体標識化合物市場洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 製薬およびバイオテクノロジー分野での調査活動の増加
      • 病気の蔓延の増加
    • 抑制要因
      • 安定同位体標識化合物のコストが高い
      • 熟練した専門家の不足
    • 機会
      • 製薬業界の成長
      • 新たなアプリケーション
    • 課題
      • 生産の複雑さ
      • 競合
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の安定同位体標識化合物市場概要

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
      • 重水素
      • 酸素-18
      • 炭素13
      • 窒素15
    • 用途別
      • 医療診断
      • 産業用
      • 調査
      • その他
    • エンドユーザー別
      • 学術・調査機関
      • 病院および診断センター
      • 製薬およびバイオテクノロジー企業
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第5章 北米の安定同位体標識化合物市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州の安定同位体標識化合物市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他欧州

第7章 アジア太平洋の安定同位体標識化合物市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • APACのその他諸国

第8章 ラテンアメリカの安定同位体標識化合物市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • 中南米の残りの地域

第9章 中東およびアフリカの安定同位体標識化合物市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • MEAの残りの部分

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の安定同位体標識化合物市場シェア分析、2022年
  • 経営パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の安定同位体標識化合物市場に対するCOVID-19の影響

12：企業プロファイル（会社概要、財務マトリックス、競合情勢、主要人材、主要競合、連絡先住所、戦略的展望、 SWOT分析）

  • TAIYO NIPPON SANSO CORPORATION
  • PerkinElmer Inc.
  • Alsachim
  • Isoflex
  • Merck KGaA
  • URENCO
  • 3C Molecular
  • Trace Sciences International
  • Cambridge Isotope Laboratories, Inc.
  • IsoSciences, LLC
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • その他の主要企業

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC23755

Global Stable Isotope Labeled Compounds Market Size Set to Touch USD 397 Million by 2029.

Global stable isotope labeled compounds market is flourishing because of an increasing research and development activities in the pharmaceutical and biotechnology sector and growing focus on treating the increasing prevalence of diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global stable isotope labeled compounds market size at USD 303.5 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global stable isotope labeled compounds market size to grow at a CAGR of 3.9% reaching a value of USD 396.71 million by 2029. Major growth drivers for the global stable isotope labeled compounds market include an increasing surge in research activities and growing trend in analytical research within the pharmaceutical and biotechnology sector. The rising incidence of cancer has notably boosted analytical investigations using stable isotope-labeled compounds. The market is set to thrive, primarily due to increasing demand for analytical activities, particularly in personalized medicine and pharmaceuticals. This convergence presents an opportunity for strong market growth. In 2022, the United States witnessed around 1.91 million new cancer cases, notably affecting the genital and digestive systems, further emphasizing the market's potential. Stable isotope tracing's role in understanding nutraceuticals' impact on cancer metabolism, as well as proteomics research, contributed to market expansion. These advances supported expectations of robust market growth. However, high cost of stable isotope labeled compounds and lack of skilled professionals are anticipated to restrain the overall market growth during the forecast period.

Global Stable Isotope Labeled Compounds Market - Overview:

Stable isotope labeling involves the utilization of non-radioactive isotopes as tracers for modeling various chemical and biochemical systems. These isotopes function as distinctive markers for compounds, detectable through techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). Commonly employed stable isotopes encompass 2H, 13C, and 15N. Researchers, particularly those engaged in metabolism-mediated toxicity studies, have shown significant interest in stable isotope-labeled compounds. Their significance has grown substantially in assessing in vivo metabolism across a wide spectrum of metabolic investigations. Beyond metabolomics research, stable isotope-labeled compounds are experiencing increasing utilization in environmental analysis, proteomics, and medical diagnostic research.

Impact of COVID-19 on Global Stable Isotope Labeled Compounds Market:

COVID-19 pandemic had a positive impact on the global stable isotope labeled compounds market. The emergence of the pandemic prompted a surge in research and development efforts worldwide as companies and institutions sought to combat the virus and devise effective management strategies. During the pandemic period, the global stable isotope labeled compounds market experienced noteworthy growth due to heightened demand for stable isotope-labeled compounds, driven by their crucial role in research related to the virus, such as investigations into the structure and dynamics of membrane proteins in pathogens like SARS-CoV-2. As the acute phase of the pandemic subsided, the market transitioned into a post-pandemic phase, and it is expected to continue its growth trajectory. The lessons learned and the increased utilization of stable isotope-labeled compounds during the pandemic are likely to contribute to healthy market expansion during the forecast period.

Global Stable Isotope Labeled Compounds Market - By End User:

On the basis of end user, the global stable isotope labeled compounds market is divided into Academic & Research Institutions, Hospital & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies segments. The pharmaceutical & biotechnology companies segment is expected to hold the highest share in the global stable isotope labeled compounds market by end user during the forecast period. These industries heavily rely on stable isotopes for drug discovery, development, and toxicity studies. Additionally, the growing focus on precision medicine and personalized therapies has intensified the demand for stable isotope-labeled compounds in these sectors. Moreover, the significant investments made by pharmaceutical giants in research and development further reinforce their prominence in utilizing stable isotopes for innovative drug-related research, ultimately contributing to their high market share.

Competitive Landscape:

Major players operating in the global stable isotope labeled compounds market include: TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Alsachim, Isoflex, Merck KGaA, URENCO, 3C Molecular, Trace Sciences International, Cambridge Isotope Laboratories, Inc., IsoSciences, LLC, Medical Isotopes, Inc., and Omicron Biochemicals, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Stable Isotope Labeled Compounds Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Stable Isotope Labeled Compounds Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Stable Isotope Labeled Compounds Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increase in research activities in the pharmaceutical and biotechnology sectors
      • 3.2.1.2. Growing prevalence of diseases
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of stable isotope labeled compounds
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Opportunities
      • 3.2.3.1. Pharmaceutical industry growth
      • 3.2.3.2. Emerging applications
    • 3.2.4. Challenges
      • 3.2.4.1. Production complexity
      • 3.2.4.2. Competition
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Stable Isotope Labeled Compounds Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Deuterium
      • 4.2.1.2. Oxygen-18
      • 4.2.1.3. Carbon-13
      • 4.2.1.4. Nitrogen-15
    • 4.2.2. By Application
      • 4.2.2.1. Medical Diagnostics
      • 4.2.2.2. Industrial
      • 4.2.2.3. Research
      • 4.2.2.4. Others
    • 4.2.3. By End User
      • 4.2.3.1. Academic & Research Institutions
      • 4.2.3.2. Hospital & Diagnostic Centers
      • 4.2.3.3. Pharmaceutical & Biotechnology Companies
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Stable Isotope Labeled Compounds Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By Application
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By Application
      • 5.2.4.2.3. By End User

6. Europe Stable Isotope Labeled Compounds Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By End User
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By Application
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By Application
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By Application
      • 6.2.4.5.3. By End User
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By Application
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By Application
      • 6.2.4.7.3. By End User
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By Application
      • 6.2.4.8.3. By End User
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By Application
      • 6.2.4.9.3. By End User

7. Asia-Pacific Stable Isotope Labeled Compounds Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By Application
      • 7.2.4.10.3. By End User

8. Latin America Stable Isotope Labeled Compounds Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By End User

9. Middle East & Africa Stable Isotope Labeled Compounds Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By Application
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By Application
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By Application
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Stable Isotope Labeled Compounds Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Stable Isotope Labeled Compounds Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. TAIYO NIPPON SANSO CORPORATION
  • 12.2. PerkinElmer Inc.
  • 12.3. Alsachim
  • 12.4. Isoflex
  • 12.5. Merck KGaA
  • 12.6. URENCO
  • 12.7. 3C Molecular
  • 12.8. Trace Sciences International
  • 12.9. Cambridge Isotope Laboratories, Inc.
  • 12.10. IsoSciences, LLC
  • 12.11. Medical Isotopes, Inc.
  • 12.12. Omicron Biochemicals, Inc.
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations